Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma. 2018

Mélanie Claps, and Sara Cerri, and Salvatore Grisanti, and Barbara Lazzari, and Vittorio Ferrari, and Elisa Roca, and Paola Perotti, and Massimo Terzolo, and Sandra Sigala, and Alfredo Berruti
Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, ASST Spedali Civili di Brescia, University of Brescia, Brescia, Italy.

UI MeSH Term Description Entries
D008297 Male Males
D008797 Metyrapone An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME. Methbipyranone,Methopyrapone,Metopiron,Metopirone,Métopirone,SU 4885
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008939 Mitotane A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression. o,p-DDD,ortho,para-DDD,Chloditan,Chlodithane,Khloditan,Lysodren,Mytotan,ortho,para DDD
D003480 Cushing Syndrome A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent. Cushing's Syndrome,Hypercortisolism,Syndrome, Cushing,Syndrome, Cushing's
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005240 Feasibility Studies Studies to determine the advantages or disadvantages, practicability, or capability of accomplishing a projected plan, study, or project. Feasibility Study,Studies, Feasibility,Study, Feasibility
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000306 Adrenal Cortex Neoplasms Tumors or cancers of the ADRENAL CORTEX. Adrenocortical Cancer,Cancer of Adrenal Cortex,Adrenal Cortex Cancer,Cancer of the Adrenal Cortex,Neoplasms, Adrenal Cortex,Adrenal Cortex Cancers,Adrenal Cortex Neoplasm,Adrenocortical Cancers,Cancer, Adrenal Cortex,Cancer, Adrenocortical,Cancers, Adrenal Cortex,Cancers, Adrenocortical,Neoplasm, Adrenal Cortex

Related Publications

Mélanie Claps, and Sara Cerri, and Salvatore Grisanti, and Barbara Lazzari, and Vittorio Ferrari, and Elisa Roca, and Paola Perotti, and Massimo Terzolo, and Sandra Sigala, and Alfredo Berruti
January 1970, The Journal of clinical endocrinology and metabolism,
Mélanie Claps, and Sara Cerri, and Salvatore Grisanti, and Barbara Lazzari, and Vittorio Ferrari, and Elisa Roca, and Paola Perotti, and Massimo Terzolo, and Sandra Sigala, and Alfredo Berruti
August 2003, Postgraduate medical journal,
Mélanie Claps, and Sara Cerri, and Salvatore Grisanti, and Barbara Lazzari, and Vittorio Ferrari, and Elisa Roca, and Paola Perotti, and Massimo Terzolo, and Sandra Sigala, and Alfredo Berruti
June 1963, The Journal of the Kentucky Medical Association,
Mélanie Claps, and Sara Cerri, and Salvatore Grisanti, and Barbara Lazzari, and Vittorio Ferrari, and Elisa Roca, and Paola Perotti, and Massimo Terzolo, and Sandra Sigala, and Alfredo Berruti
March 1967, Annales de chirurgie,
Mélanie Claps, and Sara Cerri, and Salvatore Grisanti, and Barbara Lazzari, and Vittorio Ferrari, and Elisa Roca, and Paola Perotti, and Massimo Terzolo, and Sandra Sigala, and Alfredo Berruti
August 1970, The Journal of clinical endocrinology and metabolism,
Mélanie Claps, and Sara Cerri, and Salvatore Grisanti, and Barbara Lazzari, and Vittorio Ferrari, and Elisa Roca, and Paola Perotti, and Massimo Terzolo, and Sandra Sigala, and Alfredo Berruti
May 1987, Presse medicale (Paris, France : 1983),
Mélanie Claps, and Sara Cerri, and Salvatore Grisanti, and Barbara Lazzari, and Vittorio Ferrari, and Elisa Roca, and Paola Perotti, and Massimo Terzolo, and Sandra Sigala, and Alfredo Berruti
July 2002, The American journal of psychiatry,
Mélanie Claps, and Sara Cerri, and Salvatore Grisanti, and Barbara Lazzari, and Vittorio Ferrari, and Elisa Roca, and Paola Perotti, and Massimo Terzolo, and Sandra Sigala, and Alfredo Berruti
April 2018, The Journal of clinical endocrinology and metabolism,
Mélanie Claps, and Sara Cerri, and Salvatore Grisanti, and Barbara Lazzari, and Vittorio Ferrari, and Elisa Roca, and Paola Perotti, and Massimo Terzolo, and Sandra Sigala, and Alfredo Berruti
March 1958, Southern medical journal,
Mélanie Claps, and Sara Cerri, and Salvatore Grisanti, and Barbara Lazzari, and Vittorio Ferrari, and Elisa Roca, and Paola Perotti, and Massimo Terzolo, and Sandra Sigala, and Alfredo Berruti
February 1973, Wiadomosci lekarskie (Warsaw, Poland : 1960),
Copied contents to your clipboard!